Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas

NCT00955292 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
12
Enrollment
INDUSTRY
Sponsor class

Stopped Modified dose schedule presented no advantage over previously studied schedule

Conditions

Interventions

Sponsor

Cylene Pharmaceuticals